Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1546-170X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial ; volume:28 ; number:10 ; day:12 ; month:9 ; year:2022 ; pages:2155-2161 ; date:10.2022
Nature medicine ; 28, Heft 10 (12.9.2022), 2155-2161, 10.2022
- Urheber
-
Chaft, Jamie E.
Oezkan, Filiz
Kris, Mark G.
Bunn, Paul A.
Wistuba, Ignacio I.
Kwiatkowski, David J.
Owen, Dwight H.
Tang, Yan
Johnson, Bruce E.
Lee, Jay M.
Lozanski, Gerard
Pietrzak, Maciej
Seweryn, Michal
Byun, Woo Yul
Schulze, Katja
Nicholas, Alan
Johnson, Ann
Grindheim, Jessica
Hilz, Stephanie
Shames, David S.
Rivard, Chris
Toloza, Eric
Haura, Eric B.
McNamee, Ciaran J.
Patterson, G. Alexander
Waqar, Saiama N.
Rusch, Valerie W.
Carbone, David P.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41591-022-01962-5
- URN
-
urn:nbn:de:101:1-2022122921124168465798
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:35 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Chaft, Jamie E.
- Oezkan, Filiz
- Kris, Mark G.
- Bunn, Paul A.
- Wistuba, Ignacio I.
- Kwiatkowski, David J.
- Owen, Dwight H.
- Tang, Yan
- Johnson, Bruce E.
- Lee, Jay M.
- Lozanski, Gerard
- Pietrzak, Maciej
- Seweryn, Michal
- Byun, Woo Yul
- Schulze, Katja
- Nicholas, Alan
- Johnson, Ann
- Grindheim, Jessica
- Hilz, Stephanie
- Shames, David S.
- Rivard, Chris
- Toloza, Eric
- Haura, Eric B.
- McNamee, Ciaran J.
- Patterson, G. Alexander
- Waqar, Saiama N.
- Rusch, Valerie W.
- Carbone, David P.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Author Correction: Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial
A multicenter, open-label, single-arm phase I trial of neoadjuvant nivolumab monotherapy for resectable gastric cancer
Perioperative sintilimab and neoadjuvant anlotinib plus chemotherapy for resectable non-small-cell lung cancer: a multicentre, open-label, single-arm, phase 2 trial (TD-NeoFOUR trial)
Neoadjuvant relatlimab and nivolumab in resectable melanoma
Adjuvant and Neoadjuvant Treatments for Resectable Hepatocellular Carcinoma
Neoadjuvant radiotherapy for resectable retroperitoneal sarcoma: a meta-analysis
Network meta-analysis comparing neoadjuvant chemoradiation, neoadjuvant chemotherapy and upfront surgery in patients with resectable, borderline resectable, and locally advanced pancreatic ductal adenocarcinoma
Neo-adjuvant chemotherapy plus immunotherapy in resectable N1/N2 NSCLC
Neoadjuvant Chemotherapy Switch in Borderline Resectable/Locally Advanced Pancreatic Cancer
A case study of combined neoadjuvant chemotherapy and neoadjuvant immunotherapy in resectable locally advanced esophageal cancer
Predictive factors of operability after neoadjuvant chemotherapy in resectable or borderline resectable pancreatic cancer: a single-center retrospective study
Preoperative chemotherapy and carbon ions therapy for treatment of resectable and borderline resectable pancreatic adenocarcinoma: a prospective, phase II, multicentre, single-arm study
Author Correction: Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial
A multicenter, open-label, single-arm phase I trial of neoadjuvant nivolumab monotherapy for resectable gastric cancer
Perioperative sintilimab and neoadjuvant anlotinib plus chemotherapy for resectable non-small-cell lung cancer: a multicentre, open-label, single-arm, phase 2 trial (TD-NeoFOUR trial)
Neoadjuvant relatlimab and nivolumab in resectable melanoma
Adjuvant and Neoadjuvant Treatments for Resectable Hepatocellular Carcinoma
Neoadjuvant radiotherapy for resectable retroperitoneal sarcoma: a meta-analysis
Network meta-analysis comparing neoadjuvant chemoradiation, neoadjuvant chemotherapy and upfront surgery in patients with resectable, borderline resectable, and locally advanced pancreatic ductal adenocarcinoma
Neo-adjuvant chemotherapy plus immunotherapy in resectable N1/N2 NSCLC
Neoadjuvant Chemotherapy Switch in Borderline Resectable/Locally Advanced Pancreatic Cancer
A case study of combined neoadjuvant chemotherapy and neoadjuvant immunotherapy in resectable locally advanced esophageal cancer
Predictive factors of operability after neoadjuvant chemotherapy in resectable or borderline resectable pancreatic cancer: a single-center retrospective study
Preoperative chemotherapy and carbon ions therapy for treatment of resectable and borderline resectable pancreatic adenocarcinoma: a prospective, phase II, multicentre, single-arm study
Author Correction: Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial
A multicenter, open-label, single-arm phase I trial of neoadjuvant nivolumab monotherapy for resectable gastric cancer
Perioperative sintilimab and neoadjuvant anlotinib plus chemotherapy for resectable non-small-cell lung cancer: a multicentre, open-label, single-arm, phase 2 trial (TD-NeoFOUR trial)
Neoadjuvant relatlimab and nivolumab in resectable melanoma
Adjuvant and Neoadjuvant Treatments for Resectable Hepatocellular Carcinoma
Neoadjuvant radiotherapy for resectable retroperitoneal sarcoma: a meta-analysis
Network meta-analysis comparing neoadjuvant chemoradiation, neoadjuvant chemotherapy and upfront surgery in patients with resectable, borderline resectable, and locally advanced pancreatic ductal adenocarcinoma
Neo-adjuvant chemotherapy plus immunotherapy in resectable N1/N2 NSCLC
Neoadjuvant Chemotherapy Switch in Borderline Resectable/Locally Advanced Pancreatic Cancer
A case study of combined neoadjuvant chemotherapy and neoadjuvant immunotherapy in resectable locally advanced esophageal cancer
Predictive factors of operability after neoadjuvant chemotherapy in resectable or borderline resectable pancreatic cancer: a single-center retrospective study